Science Spotlight
Search and Filter
Results per Page:
Two opposing “agendas” keep skin mutant cell clusters at an impasse
From the Beronja lab, Human Biology Division
How do antibodies evolve to kill HIV-infected cells?
From the Overbaugh and Matsen labs, Human Biology and Public Health Sciences Division
Short H2A histones, part II: a natural-born oncogene lurking in our genomes
From the Malik, Henikoff, Bleakley, and Bradley labs (Basic Sciences)
Short H2A histones, part I: parental conflict at the evolutionary scale
From the Malik and Henikoff labs (Basic Sciences)
Sequence diversity in cancer-causing viruses
From the Mullins lab, University of Washington and the Vaccine and Infectious Disease Division
Investigating pregnancy outcomes among visually impaired women in Washington State
From the Mueller Group
Remodeling the tumor microenvironment for improved CAR T-cell therapy
From the Riddell and Srivastava Labs, Clinical Research Division
Calling in the backup: expanding DCs to augment vaccine responses
From the Fling and Cheever CITN Central Immune Monitoring Lab, Vaccine and Infectious Disease Division and Clinical Research Division
Modeling the kinetics of an HIV cure
From the Schiffer group, Vaccine and Infectious Disease Division
TOP delivery of CRISPR-Cas9 machinery to primary T cells
From the Overbaugh Lab, Human Biology Division
H. pylori infection accelerates events that lead to gastric cancer development
From the Salama Lab, Human Biology Division
BV-associated bacteria thrive in inflammatory environments
From the Fredricks Lab, Vaccine and Infectious Disease Division
Healthy Eating Index 2015 scores and risk of all-cause and cause-specific mortality
From the Neuhouser Group
Selective stimulation of neoantigen-specific T cells by immunotherapy
From the Riddell Lab, Clinical Research Division
Outwitting the foe: predicting evolved antibody escape in SARS-CoV-2
From the Bloom Lab (Basic Sciences Division)
Beyond diabetes: the insulin pathway’s key role in cellular wound repair
From the Parkhurst Lab (Basic Sciences Division)
Out of pocket costs and patient outcomes in EGFR and ALK positive NSCLC
From the Goulart and Ramsey Group
Closer to the clinic: Modeling ovarian cancer metastases after surgery
From the Greenberg Lab, Clinical Research Division
Predicting SARS-CoV-2 antibody titers
From the Vaccine and Infectious Disease Division and the University of Washington